Trigoderm Gel 0.5 % w/w Fusidic acid, 0.1 % w/w Betamethasone Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

trigoderm gel 0.5 % w/w fusidic acid, 0.1 % w/w betamethasone

dechra veterinary products a/s - fusidic acid; betamethasone valerate - gel - 0.5, 0.1 percent weight/weight - betamethasone and antibiotics - dogs - antibacterial

Fusidic Acid/Betamethason Dermapharm 20 mg/g - 1 mg/g cream Belġju - Ingliż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fusidic acid/betamethason dermapharm 20 mg/g - 1 mg/g cream

dermapharm ag - fusidic acid hemihydrate 20,4 mg/g - eq. fusidic acid 20 mg/g; betamethasone valerate 1,214 mg/g - eq. betamethasone 1 mg/g - cream - 20 mg/g - 1 mg/g - fusidic acid hemihydrate 20.4 mg; betamethasone valerate 1.214 mg/g - betamethasone and antibiotics

FUCIDIN CREAM Iżrael - Ingliż - Ministry of Health

fucidin cream

dexcel ltd, israel - fusidic acid - cream - fusidic acid 20 mg/g - fusidic acid - fusidic acid - local treatment of skin infections due to sensitive strains of staphylococus aureus.

Fucithalmic 1% w/w Viscous Eye Drops / Fusidic acid 1% w/w Viscous Eye Drops Malta - Ingliż - Medicines Authority

fucithalmic 1% w/w viscous eye drops / fusidic acid 1% w/w viscous eye drops

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - fusidic acid - eye drops - fusidic acid 10 mg - ophthalmologicals

Foban New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

foban

aft pharmaceuticals ltd - fusidic acid 2%{relative} - topical cream - 2% w/w - active: fusidic acid 2%{relative} excipient: cetomacrogol 1000 cetostearyl alcohol liquid paraffin methyl hydroxybenzoate propyl hydroxybenzoate propylene glycol purified water white soft paraffin - indicated either alone or in combination with systemic therapy, in the treatment of primary and indicated for secondary skin infections caused by sensitive strains of staphylococcus aureus, streptococcus spp and corynebacterium minutissimum. primary skin infections that may be expected to respond to treatment with fusidic acid applied topically include: impetigo contagiosa, superficial folliculitis, sycosis barbae, paronychia and erythrasma; also such secondary skin infections as infected eczematoid dermatitis, infected contact dermatitis and infected cuts / abrasions.